{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:52:37Z","timestamp":1792687957699,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000001","name":"Alberta Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clnu.2024.06.037","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:18:44Z","timestamp":1720113524000},"page":"1900-1906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency"],"prefix":"10.1016","volume":"43","author":[{"given":"Pamela N.","family":"Klassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera C.","family":"Mazurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kasnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-3620","authenticated-orcid":false,"given":"Michael B.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clnu.2024.06.037_bib1","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1007\/s00330-021-07899-6","article-title":"Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer","volume":"31","author":"Salinas-Miranda","year":"2021","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.clnu.2024.06.037_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jcsm.12562","article-title":"The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer","volume":"11","author":"Derksen","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2024.06.037_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6193765","article-title":"Assessment of nutritional status, digestion and absorption, and quality of life in patients with locally advanced pancreatic cancer","volume":"2017","author":"Witvliet-van Nierop","year":"2017","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas cancer-associated weight loss","volume":"24","author":"Hendifar","year":"2019","journal-title":"Oncol"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MCG.0b013e31829f56e7","article-title":"A\u00a0prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor","volume":"48","author":"Sikkens","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1053\/j.gastro.2023.07.007","article-title":"AGA clinical practice update on the epidemiology, evaluation, and management of exocrine pancreatic insufficiency: expert review","volume":"165","author":"Whitcomb","year":"2023","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clnu.2024.06.037_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10620-023-08184-w","article-title":"Exocrine pancreatic insufficiency dosing guidelines for pancreatic enzyme replacement therapy vary widely across disease types","volume":"69","author":"Lewis","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.clnu.2024.06.037_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pan.2015.12.006","article-title":"Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency","volume":"16","author":"Smith","year":"2016","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.clnu.2024.06.037_bib10","article-title":"Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer","volume":"7","author":"Roeyen","year":"2022","journal-title":"ESMO Open [Internet]"},{"issue":"8","key":"10.1016\/j.clnu.2024.06.037_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.pan.2018.09.012","article-title":"Diagnosis and management of pancreatic cancer in adults: a summary of guidelines from the UK National Institute for Health and Care Excellence","volume":"18","author":"O'Reilly","year":"2018","journal-title":"Pancreatology"},{"issue":"11","key":"10.1016\/j.clnu.2024.06.037_bib12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s12094-020-02350-6","article-title":"Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer","volume":"22","author":"Martin-Perez","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MPA.0000000000002049","article-title":"The impact of pancreatic enzyme replacement therapy on patients with advanced pancreatic adenocarcinoma","volume":"51","author":"Landers","year":"2022","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.clnu.2024.06.037_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gut.42.1.92","article-title":"Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region","volume":"42","author":"Bruno","year":"1998","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.clnu.2024.06.037_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MPA.0000000000000767","article-title":"The role of pancreatic enzyme replacement therapy in unresectable pancreatic cancer: a prospective cohort study","volume":"46","author":"Saito","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.clnu.2024.06.037_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.688889","article-title":"Pancreatic enzyme replacement therapy in patients undergoing first-line gemcitabine plus nab-paclitaxel for advanced pancreatic adenocarcinoma","volume":"11","author":"Trestini","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.clnu.2024.06.037_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.pan.2016.09.001","article-title":"Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial","volume":"16","author":"Woo","year":"2016","journal-title":"Pancreatology"},{"issue":"7","key":"10.1016\/j.clnu.2024.06.037_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/MPA.0000000000001079","article-title":"A\u00a0multicenter open-label randomized controlled trial of pancreatic enzyme replacement therapy in unresectable pancreatic cancer","volume":"47","author":"Saito","year":"2018","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.clnu.2024.06.037_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2016","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2024.06.037_bib20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00520-017-3602-2","article-title":"Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC)","volume":"25","author":"Zdenkowski","year":"2017","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.clnu.2024.06.037_bib21","article-title":"A\u00a0national audit of pancreatic enzyme prescribing in pancreatic cancer from 2015 to 2023 in England using OpenSAFELY-TPP","volume":"39","author":"Lemanska","year":"2023","journal-title":"Semin Oncol Nurs [Internet]"},{"issue":"17","key":"10.1016\/j.clnu.2024.06.037_bib22","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.3390\/cancers15174368","article-title":"Muscle and adipose wasting despite disease control: unaddressed side effects of palliative chemotherapy for pancreatic cancer","volume":"15","author":"Klassen","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A\u00a0practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"issue":"5","key":"10.1016\/j.clnu.2024.06.037_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.clnu.2022.03.016","article-title":"Assessing dynamic change in muscle during treatment of patients with cancer: precision testing standards","volume":"41","author":"Arribas","year":"2022","journal-title":"Clin Nutr [Internet]"},{"issue":"6","key":"10.1016\/j.clnu.2024.06.037_bib25","first-page":"1","article-title":"The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study","volume":"12","author":"Landers","year":"2019","journal-title":"Palliat Care Res Treat"},{"key":"10.1016\/j.clnu.2024.06.037_bib26","article-title":"The influence of omega-3 fatty acids on skeletal muscle protein turnover in health, disuse, and disease","volume":"6","author":"McGlory","year":"2019","journal-title":"Front Nutr [Internet]"},{"issue":"2","key":"10.1016\/j.clnu.2024.06.037_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00223-012-9645-y","article-title":"Vitamin D and its role in skeletal muscle","volume":"92","author":"Ceglia","year":"2013","journal-title":"Calcif Tissue Int [Internet]"},{"key":"10.1016\/j.clnu.2024.06.037_bib28","unstructured":"Rondanelli M, Klersy C, Terracol G, Talluri J, Maugeri R, Guido D, et\u00a0al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly 1,2."},{"issue":"8","key":"10.1016\/j.clnu.2024.06.037_bib29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.pan.2020.09.012","article-title":"Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancer","volume":"20","author":"Carnie","year":"2020","journal-title":"Pancreatology"},{"issue":"9","key":"10.1016\/j.clnu.2024.06.037_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/MPA.0000000000001906","article-title":"Pancreatic enzyme replacement therapy for patients diagnosed with pancreaticobiliary cancer","volume":"50","author":"Carnie","year":"2021","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.clnu.2024.06.037_bib31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.pan.2021.05.299","article-title":"Pancreatic enzyme replacement therapy in patients with pancreatic cancer: a national prospective study","volume":"21","author":"Harvey","year":"2021","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.clnu.2024.06.037_bib32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/MPA.0000000000001330","article-title":"Frequency of appropriate use of pancreatic enzyme replacement therapy and symptomatic response in pancreatic cancer patients","volume":"48","author":"Barkin","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.clnu.2024.06.037_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.clnu.2024.06.037_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO clinical practice guidelines\u2606","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424002292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424002292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T21:03:34Z","timestamp":1721941414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424002292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0261561424002292"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.06.037","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}